Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Healthtrust
Dow
Mallinckrodt
Baxter
Teva
Covington
Harvard Business School
Daiichi Sankyo
UBS

Generated: February 22, 2018

DrugPatentWatch Database Preview

FENOPROFEN CALCIUM - Generic Drug Details

« Back to Dashboard

What are the generic sources for fenoprofen calcium and what is the scope of fenoprofen calcium patent protection?

Fenoprofen calcium
is the generic ingredient in two branded drugs marketed by Am Therap, Aurolife Pharma Llc, Halsey, Par Pharm, Quantum Pharmics, Warner Chilcott, Watson Labs, Xspire Pharma, Actavis Elizabeth, Dava Pharms Inc, Ivax Sub Teva Pharms, Sun Pharm Industries, Usl Pharma, Watson Labs Teva, and Dista, and is included in thirty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for fenoprofen calcium. Thirteen suppliers are listed for this compound.
Pharmacology for FENOPROFEN CALCIUM
Medical Subject Heading (MeSH) Categories for FENOPROFEN CALCIUM

US Patents and Regulatory Information for FENOPROFEN CALCIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Teva FENOPROFEN CALCIUM fenoprofen calcium TABLET;ORAL 072407-001 Aug 17, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aurolife Pharma Llc FENOPROFEN CALCIUM fenoprofen calcium CAPSULE;ORAL 072395-001 Oct 17, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Pharm FENOPROFEN CALCIUM fenoprofen calcium TABLET;ORAL 072429-001 Aug 17, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Am Therap FENOPROFEN CALCIUM fenoprofen calcium CAPSULE;ORAL 072307-001 Aug 22, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Usl Pharma FENOPROFEN CALCIUM fenoprofen calcium TABLET;ORAL 072362-001 Aug 17, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs FENOPROFEN CALCIUM fenoprofen calcium CAPSULE;ORAL 072293-001 Aug 17, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aurolife Pharma Llc FENOPROFEN CALCIUM fenoprofen calcium TABLET;ORAL 072396-001 Oct 17, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs FENOPROFEN CALCIUM fenoprofen calcium CAPSULE;ORAL 072982-001 Aug 19, 1991 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dista NALFON fenoprofen calcium TABLET;ORAL 017710-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Xspire Pharma NALFON fenoprofen calcium CAPSULE;ORAL 017604-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for FENOPROFEN CALCIUM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Xspire Pharma NALFON fenoprofen calcium CAPSULE;ORAL 017604-003 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Xspire Pharma NALFON fenoprofen calcium CAPSULE;ORAL 017604-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Dista NALFON fenoprofen calcium TABLET;ORAL 017710-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Fuji
Teva
Argus Health
McKinsey
Colorcon
McKesson
Boehringer Ingelheim
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot